Su1440 Characteristics of Treatment Refractory GERD - Switching Proton Pump Inhibitor Based on Patient's CYP2C19 Genotype Is an Effective Management?–a Prospective, Multicenter, Open Label Study

Authors :: Eiji Umegaki
Satoshi Harada
Shoko Edogawa
Kazuhiro Ota
Toshihisa Takeuchi
Kazuhide Higuchi
Satoshi Tokioka
Yuichi Kojima
Source :: Gastrointestinal Endoscopy. 77:AB324
Publication Year :: 2013
Publisher :: Elsevier BV, 2013.

Subjects :: medicine.medical_specialty
business.industry
Treatment refractory
medicine.drug_class
Cyp2c19 genotype
Gastroenterology
Proton-pump inhibitor
Effective management
medicine.disease
Surgery
Open label study
Internal medicine
medicine
GERD
Radiology, Nuclear Medicine and imaging
business

Tools